Scientists discover the brain's 'scratch stop' signal for chronic itch relief

Scientists discover the brain's 'scratch stop' signal for chronic itch relief

Erik Holland
Erik Holland•
• 2 Min.
A black true bug is sitting on a person's skin.

Scientists discover the brain's 'scratch stop' signal for chronic itch relief

Scientists have uncovered how a specific ion channel controls the urge to scratch—and when to stop. The discovery, led by Professor Roberta Gualdani of KU Leuven, reveals that the TRPV4 channel acts like a biological 'braking system' for scratching behaviour. The findings were presented at the 70th Annual Meeting of the Biophysical Society in San Francisco last week.

The TRPV4 ion channel plays a dual role in itch regulation. In skin cells, it triggers the sensation of itch itself. But in sensory neurons, it does the opposite—it helps the brain recognise when scratching has gone on long enough.

Mice without the TRPV4 channel behaved differently when exposed to itch-inducing substances. They scratched less often but kept scratching for much longer periods. Without the channel, their brains failed to send the usual signal that enough scratching had occurred.

This lack of a 'stop' signal could explain why some people with chronic itch conditions, such as atopic dermatitis, end up scratching excessively. The research suggests that TRPV4 does not just influence the itch sensation but actively limits how long scratching lasts.

The implications stretch beyond basic science. Around five chronic skin diseases—including prurigo nodularis, atopic dermatitis, and psoriasis—are linked to severe itching. Current research is already exploring whether targeting TRPV4 or similar channels could lead to new treatments for these conditions.

The findings open a potential path for developing medications that control itch without interfering with the body's natural scratching termination signals. By focusing on the TRPV4 channel, future therapies might help patients manage chronic itch more effectively. Research into prurigo nodularis and atopic dermatitis is already underway to test this approach.

Neueste Nachrichten